Cytek Biosciences Inc (CTKB)
Healthcare
Medical Devices
—
4.20 $
-2.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Cytek Biosciences Inc (CTKB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -2.7 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.9 | -4.2 | 9.5 | 4.0 | 6.2 | 13 | 2.0 | -0.1 | 0.1 | -3.9 | -0.8 | -2.7 | -7.3 | |
| 2.4 | 2.6 | 2.4 | 2.5 | 2.5 | 2.8 | 2.7 | 2.9 | 3.0 | 3.1 | 3.0 | 2.8 | 12 | |
| 5.9 | 5.8 | 5.7 | 5.6 | 7.2 | 7.1 | 7.0 | 6.6 | 6.8 | 5.6 | 5.5 | 4.9 | 23 | |
| 6.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -5.1 | -5.3 | -3.8 | 1.8 | 8.1 | -10.0 | -5.5 | 3.0 | -0.8 | -3.6 | -3.5 | 9.0 | 1.2 | |
| 1.4 | 1.4 | 1.6 | 0.6 | 1.2 | 0.8 | 0.9 | 0.9 | 1.6 | 0.7 | 1.0 | 2.2 | 5.4 | |
| 2.8 | 43 | 29 | -5.8 | 2.0 | -16 | -63 | 9.5 | -16 | 19 | -1.8 | -27 | -26 | |
| 0.5 | 0.4 | – | – | – | – | – | – | – | – | – | – | – | |
| -1.0 | -8.4 | -35 | -0.1 | -2.7 | -12 | -7.0 | -11 | -4.5 | 0.0 | 0.0 | 0.0 | -4.4 | |
| -0.1 | – | – | – | – | -0.1 | 2.6 | -0.8 | 1.2 | 1.9 | -1.5 | 4.2 | 5.9 | |
| 0.2 | -8.3 | -34 | 1.6 | -1.7 | -12 | -3.6 | -12 | -2.6 | 1.9 | -1.2 | 4.0 | 2.1 | |
| -0.9 | 32 | 4.0 | 1.5 | 8.8 | -16 | -64 | -3.4 | -20 | 18 | -2.4 | -25 | -30 | |
| -4.2 | -5.6 | 8.0 | 3.3 | 5.0 | 12 | 1.1 | -1.0 | -1.5 | -4.6 | -1.8 | -4.9 | -13 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.